James Baggs

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population
    Lisa A Jackson
    Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 24:151-6. 2006
  2. pmc Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, USA
    BMC Infect Dis 9:37. 2009
  3. ncbi request reprint Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program
    James Baggs
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, 1600 Clifton Rd, Mailstop E61, Atlanta, GA 30333, USA
    Clin Infect Dis 40:1133-40. 2005
  4. doi request reprint The Vaccine Safety Datalink: a model for monitoring immunization safety
    James Baggs
    Immunization Safety Office, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mail Stop D25, Atlanta, GA 30333, USA
    Pediatrics 127:S45-53. 2011
  5. doi request reprint Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
    Julianne Gee
    Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 29:8279-84. 2011
  6. doi request reprint Intussusception and rotavirus vaccination: a review of the available evidence
    Manish M Patel
    Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Expert Rev Vaccines 8:1555-64. 2009
  7. pmc Influence of host factors on immunoglobulin G concentration in oral fluid specimens
    Timothy C Granade
    Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road D 12, Atlanta, GA 30333, USA
    Clin Diagn Lab Immunol 9:194-7. 2002
  8. ncbi request reprint Adequacy of surveillance to detect endemic rubella transmission in the United States
    Francisco Averhoff
    National Center for Preparedness, Detection, and Control of Infectious Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S151-7. 2006
  9. doi request reprint Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007
    Penina Haber
    Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
    Pediatrics 121:1206-12. 2008
  10. doi request reprint Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza
    Natalie L McCarthy
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS D26, Atlanta, GA 30333, USA
    Vaccine 29:4891-6. 2011

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population
    Lisa A Jackson
    Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 24:151-6. 2006
    ..5 for both comparisons with the third PPV group). These findings do not suggest that a third PPV dose is associated with an increased risk of medically attended injection site reactions compared with a first or second PPV dose...
  2. pmc Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, USA
    BMC Infect Dis 9:37. 2009
    ..To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project...
  3. ncbi request reprint Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program
    James Baggs
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, 1600 Clifton Rd, Mailstop E61, Atlanta, GA 30333, USA
    Clin Infect Dis 40:1133-40. 2005
    ..This report describes the frequency of such symptoms among 936 adult smallpox vaccinees with and without a history of prior smallpox vaccination...
  4. doi request reprint The Vaccine Safety Datalink: a model for monitoring immunization safety
    James Baggs
    Immunization Safety Office, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mail Stop D25, Atlanta, GA 30333, USA
    Pediatrics 127:S45-53. 2011
    ..With its recent enhancements, the VSD provides scientific expertise, continues to develop innovative approaches for vaccine-safety research, and may serve as a model for other patient safety collaborative research projects...
  5. doi request reprint Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
    Julianne Gee
    Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 29:8279-84. 2011
    ..In 7 large managed care organizations (MCOs), we performed a post-licensure safety assessment of quadrivalent human papillomavirus vaccine (HPV4) among 9-26 year-old female vaccine recipients between August 2006 and October 2009...
  6. doi request reprint Intussusception and rotavirus vaccination: a review of the available evidence
    Manish M Patel
    Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Expert Rev Vaccines 8:1555-64. 2009
    ..We review these safety data for the new vaccines and for Rotashield to provide background information relevant for considering age recommendations for rotavirus vaccination...
  7. pmc Influence of host factors on immunoglobulin G concentration in oral fluid specimens
    Timothy C Granade
    Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road D 12, Atlanta, GA 30333, USA
    Clin Diagn Lab Immunol 9:194-7. 2002
    ..0001), bleeding gums (+6.35 microg/ml, P = 0.0001), and time since the last meal (+3.55 microg/ml, >6 h, P = 0.0001). These factors could impact diagnostic methods that rely on the immunoglobulin concentration in OF specimens...
  8. ncbi request reprint Adequacy of surveillance to detect endemic rubella transmission in the United States
    Francisco Averhoff
    National Center for Preparedness, Detection, and Control of Infectious Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S151-7. 2006
    ..It is necessary to validate that the observed absence of rubella is due to the disappearance of disease rather than a failure of rubella surveillance...
  9. doi request reprint Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007
    Penina Haber
    Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
    Pediatrics 121:1206-12. 2008
    ..Although the new rotavirus vaccine (RotaTeq; Merck, West Point, PA) introduced in 2006 was not associated with intussusception in prelicensure trials, additional monitoring is important to ensure a complete safety profile...
  10. doi request reprint Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza
    Natalie L McCarthy
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS D26, Atlanta, GA 30333, USA
    Vaccine 29:4891-6. 2011
    ..Additional work will be required at these sites to overcome the barriers, which included privacy and confidentiality laws, time constraints brought on by the pandemic, as well as data quality concerns...
  11. doi request reprint Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012
    Penina Haber
    National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Pediatrics 131:1042-9. 2013
    ..In 2006 and 2008, 2 new rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) were introduced in the United States...
  12. doi request reprint Comparison of epidemiologic methods for active surveillance of vaccine safety
    David L McClure
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA
    Vaccine 26:3341-5. 2008
    ..We performed a simulation study to compare four study designs [(matched-cohort, vaccinated-only (risk-interval) cohort, case-control, and self-controlled case-series (SCCS)] in the context of vaccine safety active surveillance...